|1.||Taylor, Kathryn: 2 articles (07/2003 - 03/2002)|
|2.||Dent, David M: 2 articles (07/2003 - 03/2002)|
|3.||Mall, Anwar S: 2 articles (07/2003 - 03/2002)|
|4.||Kahn, Delawir: 2 articles (07/2003 - 03/2002)|
|5.||Tonai, Shunsuke: 2 articles (01/2003 - 09/2002)|
|6.||Okabe, Susumu: 2 articles (01/2003 - 09/2002)|
|7.||Maeda, Kazuhiko: 2 articles (01/2003 - 09/2002)|
|8.||Rodríguez Gonzalez, Omaira: 1 article (09/2015)|
|9.||Génesis, Jara: 1 article (09/2015)|
|10.||Raquel, Ferrnandez: 1 article (09/2015)|
|1.||cetuximab (Erbitux)FDA Link
|4.||Octreotide (Sandostatin)FDA LinkGeneric
|5.||Staphylococcal Protein A (A, Protein)IBA
10/01/1979 - "Transient hypertrophic gastropathy in childhood: a protein-losing gastropathy distinct from Menetrier's disease."
01/01/2015 - "Menetrier's disease is a rare entity in children, characterized by a protein-losing gastroenteropathy with thickening of the gastric mucosa and generalized edema. "
08/01/1978 - "A patient with exocrine pancreatic insufficiency and hypoalbuminemic edema was shown also to have a protein-losing gastropathy secondary to giant hypertrophic gastritis (Ménétrier's disease). "
|6.||Epidermal Growth Factor Receptor (EGF Receptor)IBA
01/01/2009 - "Menetrier's disease is a rare hyperproliferative disorder of the stomach caused by an overexpression of tumour growth factor α, a ligand for the tyrokinase epidermal growth factor receptor, resulting in a selective expansion of surface mucous cells in the body and fundus of the stomach. "
10/01/2004 - "Members of the Reg family, RegIIIbeta and RegIIIgamma, were greatly elevated in mice with hypertrophic gastritis, whereas RegI and amphiregulin (an EGF receptor ligand) were more modestly and/or inconsistently induced. "
|7.||Pancreatic Polypeptide (Pancreatic Polypeptide (PP))IBA
07/01/1989 - "Pancreatic polypeptide and insulin-secreting tumor in a dog with duodenal ulcers and hypertrophic gastritis."
08/01/1984 - "Hamartomatous polyp in adult oxyntic mucosa, hyperplastic oxyntic mucosa in Menetrier's disease and atrophic oxyntic mucosa in a remnant stomach with cancer showed scattered glucagon-glicentin cells, but few or no cells containing bovine pancreatic polypeptide. "
07/01/2003 - "All stomachs stained positively for MUC4, 5AC and 6 and showed no or little staining with MUC2 and 3. Thus, Menetrier's disease is characterized by an excess quantity of mucus secretion, but differs little from normal stomachs with regards to the types of mucin produced. "
03/01/2002 - "The fragmentation pattern of mucin in Menetrier's disease demonstrated less large polymeric mucin than the control. "
03/01/1975 - "Menetrier's disease with normal serum gastrin."
01/01/2000 - "We report a case of pseudo-Zollinger-Ellison syndrome in a 17-year-old man presenting with gastrin levels exceeding 2000 pmol/l and BAO 24 mEq/hr. Histologically, apart from hypertrophic gastritis with the thickening of mucosal folds and diffuse G-cell hyperplasia, gastric mucosa was found to contain foci of pancreatic metaplasia."
01/01/2014 - "Canine giant hypertrophic gastritis treated successfully with partial gastrectomy."
09/01/2015 - "Robot-assisted laparoscopic gastrectomy for Menetrier's disease."
12/01/2012 - "Partial gastrectomy was performed and histology was consistent with hypertrophic gastritis with typical features of Ménétrier's disease. "
10/01/1987 - "We suggest that in documented Menetrier's disease elective total gastrectomy should still be considered as a treatment of choice."
04/30/1978 - "[Total gastrectomy for Menetrier's disease and reconstruction of alimentary continuity, using the Moricca technic]."
|3.||Nutritional Support (Artificial Feeding)
|4.||Home Parenteral Nutrition
02/01/1986 - "Home parenteral nutrition in a child with Menetrier disease."